Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Cognitive impairment in schizophrenia: aetiology, pathophysiology, and treatment
Robert A. McCutcheon, Richard S.E. Keefe, Philip McGuire
Molecular Psychiatry (2023) Vol. 28, Iss. 5, pp. 1902-1918
Open Access | Times Cited: 305

Showing 1-25 of 305 citing articles:

Genomic findings in schizophrenia and their implications
Michael J. Owen, Sophie E. Legge, Elliott Rees, et al.
Molecular Psychiatry (2023) Vol. 28, Iss. 9, pp. 3638-3647
Open Access | Times Cited: 56
A concerted neuron–astrocyte program declines in ageing and schizophrenia
Emi Ling, James Nemesh, Melissa Goldman, et al.
Nature (2024) Vol. 627, Iss. 8004, pp. 604-611
Open Access | Times Cited: 51
Schizophrenia: from neurochemistry to circuits, symptoms and treatments
Oliver Howes, Bernard R Bukala, Katherine Beck
Nature Reviews Neurology (2023) Vol. 20, Iss. 1, pp. 22-35
Closed Access | Times Cited: 46
Evidence-based psychosocial interventions in schizophrenia: a critical review
Sergio Barlati, Gabriele Nibbio, Antonio Vita
Current Opinion in Psychiatry (2024) Vol. 37, Iss. 3, pp. 131-139
Open Access | Times Cited: 22
Mendelian randomization: causal inference leveraging genetic data
Lane G. Chen, Justin D. Tubbs, Zipeng Liu, et al.
Psychological Medicine (2024) Vol. 54, Iss. 8, pp. 1461-1474
Open Access | Times Cited: 19
Cognitive Function and Variability in Antipsychotic Drug–Naive Patients With First-Episode Psychosis
Maria Lee, Martin Cernvall, Jacqueline Borg, et al.
JAMA Psychiatry (2024) Vol. 81, Iss. 5, pp. 468-468
Open Access | Times Cited: 15
Overview of Novel Antipsychotic Drugs: State of the Art, New Mechanisms, and Clinical Aspects of Promising Compounds
Letizia Biso, Marco Carli, Marco Scarselli, et al.
Biomedicines (2025) Vol. 13, Iss. 1, pp. 85-85
Open Access | Times Cited: 1
Clinical practice guidelines for assessment and management of cognitive impairment in schizophrenia
Sandeep Grover, Debadatta Mohapatra, Sridhar Vaitheswaran, et al.
Indian Journal of Psychiatry (2025) Vol. 67, Iss. 1, pp. 65-83
Open Access | Times Cited: 1
Roles of the Oxytocin Receptor (OXTR) in Human Diseases
Karolina Pierzynowska, Lidia Gaffke, Magdalena Żabińska, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 4, pp. 3887-3887
Open Access | Times Cited: 29
Sulcal variability in anterior lateral prefrontal cortex contributes to variability in reasoning performance among young adults
Ethan H. Willbrand, Samantha Jackson, Szeshuen Chen, et al.
Brain Structure and Function (2024) Vol. 229, Iss. 2, pp. 387-402
Open Access | Times Cited: 14
New Drug Treatments for Schizophrenia: A Review of Approaches to Target Circuit Dysfunction
Oliver Howes, Eleanor Dawkins, Maria Lobo, et al.
Biological Psychiatry (2024) Vol. 96, Iss. 8, pp. 638-650
Open Access | Times Cited: 14
Pharmacological Treatment of Cognitive Impairment Associated With Schizophrenia: State of the Art and Future Perspectives
Antonio Vita, Gabriele Nibbio, Sergio Barlati
Schizophrenia Bulletin Open (2024) Vol. 5, Iss. 1
Open Access | Times Cited: 12
The magnitude and variability of neurocognitive performance in first-episode psychosis: a systematic review and meta-analysis of longitudinal studies
Ana Catalán, Robert A. McCutcheon, Clàudia Aymerich, et al.
Translational Psychiatry (2024) Vol. 14, Iss. 1
Open Access | Times Cited: 11
Parvalbumin interneuron deficits in schizophrenia
Oscar Marı́n
European Neuropsychopharmacology (2024) Vol. 82, pp. 44-52
Open Access | Times Cited: 10
Psychosis as a disorder of muscarinic signalling: psychopathology and pharmacology
Robert A. McCutcheon, Lilian Weber, Matthew M. Nour, et al.
The Lancet Psychiatry (2024) Vol. 11, Iss. 7, pp. 554-565
Closed Access | Times Cited: 10
Co‐administration of probiotic and vitamin D significantly improves cognitive function in schizophrenic patients: A double‐blinded randomized controlled trial
Aida Mohammadi, Gita Sadighi, Ali Nazeri Astaneh, et al.
Neuropsychopharmacology Reports (2024) Vol. 44, Iss. 2, pp. 389-398
Open Access | Times Cited: 9
Antecedents of major depressive, bipolar, and psychotic disorders: A systematic review and meta-analysis of prospective studies
Rudolf Uher, Barbara Pavlová, Sara Najafi, et al.
Neuroscience & Biobehavioral Reviews (2024) Vol. 160, pp. 105625-105625
Closed Access | Times Cited: 8
New clues for the role of cerebellum in schizophrenia and the associated cognitive impairment
Pawan Faris, Doris Pischedda, Fulvia Palesi, et al.
Frontiers in Cellular Neuroscience (2024) Vol. 18
Open Access | Times Cited: 8
Genetic variants in COMT and ESR1 genes shape treatment response to raloxifene in schizophrenia-spectrum disorders
Bodyl A. Brand, Anne Jetske Boer, Janna N. de Boer, et al.
Psychoneuroendocrinology (2025) Vol. 172, pp. 107274-107274
Open Access | Times Cited: 1
Towards Enhancing Drug Development Methodology to Treat Cognitive Impairment Associated With Schizophrenia and Other Neuropsychiatric Conditions: Insights From 2 Decades of Clinical Trials
W. P. Horan, Amir H Kalali, Stephen K. Brannan, et al.
Schizophrenia Bulletin (2025)
Open Access | Times Cited: 1
Urolithin A ameliorates schizophrenia-like behaviors and cognitive impairments in female rats by modulating NLRP3 signaling
Zhengyuan Huang, Guang‐Hui Chen, Zhongyu Ren, et al.
International Immunopharmacology (2025) Vol. 151, pp. 114336-114336
Closed Access | Times Cited: 1
Reduced Visual Function in Schizotypal Traits: An Exploratory Study
Emsal Llapashtica, John L. Barbur, Corinna Haenschel
Schizophrenia Bulletin (2025) Vol. 51, Iss. Supplement_2, pp. S205-S213
Open Access | Times Cited: 1
Novel Compounds in the Treatment of Schizophrenia—A Selective Review
Eva-Maria Tsapakis, Kalliopi Diakaki, Apostolos Miliaras, et al.
Brain Sciences (2023) Vol. 13, Iss. 8, pp. 1193-1193
Open Access | Times Cited: 17
Cognitive and inflammatory heterogeneity in severe mental illness: Translating findings from blood to brain
Linn Sofie Sæther, Attila Szabó, Ibrahim A. Akkouh, et al.
Brain Behavior and Immunity (2024) Vol. 118, pp. 287-299
Open Access | Times Cited: 7
Exploring causal mechanisms of psychosis risk
Dominic Oliver, Edward Chesney, Alexis E. Cullen, et al.
Neuroscience & Biobehavioral Reviews (2024) Vol. 162, pp. 105699-105699
Open Access | Times Cited: 6
Page 1 - Next Page

Scroll to top